JAK-STAT and G-protein-coupled receptor signaling pathways are frequently altered in epitheliotropic intestinal T-cell lymphoma.

Published

Journal Article

Epitheliotropic intestinal T-cell lymphoma (EITL, also known as type II enteropathy-associated T-cell lymphoma) is an aggressive intestinal disease with poor prognosis and its molecular alterations have not been comprehensively characterized. We aimed to identify actionable easy-to-screen alterations that would allow better diagnostics and/or treatment of this deadly disease. By performing whole-exome sequencing of four EITL tumor-normal pairs, followed by amplicon deep sequencing of 42 tumor samples, frequent alterations of the JAK-STAT and G-protein-coupled receptor (GPCR) signaling pathways were discovered in a large portion of samples. Specifically, STAT5B was mutated in a remarkable 63% of cases, JAK3 in 35% and GNAI2 in 24%, with the majority occurring at known activating hotspots in key functional domains. Moreover, STAT5B locus carried copy-neutral loss of heterozygosity resulting in the duplication of the mutant copy, suggesting the importance of mutant STAT5B dosage for the development of EITL. Dysregulation of the JAK-STAT and GPCR pathways was also supported by gene expression profiling and further verified in patient tumor samples. In vitro overexpression of GNAI2 mutants led to the upregulation of pERK1/2, a member of MEK-ERK pathway. Notably, inhibitors of both JAK-STAT and MEK-ERK pathways effectively reduced viability of patient-derived primary EITL cells, indicating potential therapeutic strategies for this neoplasm with no effective treatment currently available.

Full Text

Duke Authors

Cited Authors

  • Nairismägi, M-L; Tan, J; Lim, JQ; Nagarajan, S; Ng, CCY; Rajasegaran, V; Huang, D; Lim, WK; Laurensia, Y; Wijaya, GC; Li, ZM; Cutcutache, I; Pang, WL; Thangaraju, S; Ha, J; Khoo, LP; Chin, ST; Dey, S; Poore, G; Tan, LHC; Koh, HKM; Sabai, K; Rao, H-L; Chuah, KL; Ho, Y-H; Ng, S-B; Chuang, S-S; Zhang, F; Liu, Y-H; Pongpruttipan, T; Ko, YH; Cheah, P-L; Karim, N; Chng, W-J; Tang, T; Tao, M; Tay, K; Farid, M; Quek, R; Rozen, SG; Tan, P; Teh, BT; Lim, ST; Tan, S-Y; Ong, CK

Published Date

  • June 2016

Published In

Volume / Issue

  • 30 / 6

Start / End Page

  • 1311 - 1319

PubMed ID

  • 26854024

Pubmed Central ID

  • 26854024

Electronic International Standard Serial Number (EISSN)

  • 1476-5551

Digital Object Identifier (DOI)

  • 10.1038/leu.2016.13

Language

  • eng

Conference Location

  • England